Articles by Daniel Marsh
Wealth Managers Boost Leveraged Nasdaq ETF Bets Ahead of Market Correction
SEC filings reveal several wealth management firms significantly raised their holdings in leveraged Nasdaq-100 ETFs like TQQQ and QLD in late 2025. These bets are now under pressure as the Nasdaq Composite has entered correction territory.
Pfizer Shares Reach New Peak Amid Divergent Views on Future Growth
Pfizer shares surged to a 52-week high of $28.30, driven by robust quarterly results and promising oncology data. Analysts remain divided on whether the stock's rally is sustainable given looming growth challenges.
Biogen to Acquire Apellis in $5.6B Deal, Adding Rare Disease Portfolio
Biogen has entered an agreement to acquire Apellis Pharmaceuticals for approximately $5.6 billion in cash. The deal provides Apellis shareholders $41 per share upfront, with potential additional payments based on sales performance of the eye drug Syfovre.
JPMorgan Commits $80 Billion to Small Business, Expands Private Capital Unit
JPMorgan Chase unveiled a decade-long $80 billion lending program aimed at small businesses and is expanding its private capital team to serve companies staying private longer.
Blackstone Enlists Top Golfer Fleetwood in Wealth Management Expansion
Blackstone has appointed professional golfer Tommy Fleetwood as its inaugural global brand ambassador, a strategic move to attract high-net-worth individual investors. The firm's private wealth unit now oversees $302 billion in assets as competition for affluent capital intensifies.
Indian Markets Begin Fiscal Year Under Pressure as Crude, Currency Weigh
Indian equities enter the new fiscal year under significant strain, with benchmarks recording their steepest annual declines since 2020. The rupee hit a historic low while Brent crude prices hovered near $115, exacerbating inflation and trade deficit concerns.
Shanghai Composite Tumbles 0.8%, Posts Steepest Monthly Drop Since Early 2022
The Shanghai Composite Index declined 0.8% to 3,891.86, marking its worst monthly performance since January 2022. Losses came despite an official manufacturing PMI reading that beat forecasts.
Shenzhen Market Plunges as Growth Stocks Retreat Despite Positive Factory Data
Shenzhen stocks declined sharply on Tuesday, with the ChiNext board dropping 2.7%, as investor concerns over energy prices and supply chain risks overshadowed positive manufacturing data.
Hong Kong Stocks Post Modest Gain Amid Mixed March Performance
Hong Kong's Hang Seng Index closed slightly higher on Tuesday, gaining 0.15% to 24,788.14, but recorded a 6.9% decline for March, marking its poorest monthly performance since January 2024.
SCHD ETF Boosts Healthcare in Rebalance as Dividend Fund Inflows Surge
The Schwab U.S. Dividend Equity ETF (SCHD) increased its healthcare allocation to 18.5% during its yearly portfolio update, adding Abbott Laboratories and UnitedHealth Group. The fund gathered nearly $4 billion in the first quarter as investors poured a total of $24.1 billion into U.S. dividend-focused funds, marking the strongest quarterly start since 2022.